ArticleInternal medicine (Tokyo, Japan)2020

SGLT2 Inhibitor and GLP-1 Receptor Agonist Combination Therapy Substantially Improved the Renal Function in a Patient with Type 2 Diabetes: Implications for Additive Renoprotective Effects of the Two Drug Classes.

Kenta Nonomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.